| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
2 companies
Oyler John serves as a Chief Executive Officer at BEIGF and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 0 buys and 464 sells.
Historically, Oyler John's trades have earned a middling insider score of 58/100 across 45 rated trades. Over a 12-month horizon, 51.4% of those trades were profitable, with an average 12-month return of +4.8%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | BEIGF Beone Medicines AG | Chief Executive Officer | Sell10b5-1 | 240,810 | $359.12 | $86,480,472.01 | -100% | - | - | |
| Jul 21, 2026 | BEIGF Beone Medicines AG | Chief Executive Officer | Sale+OE10b5-1 | 109,713 | $315.28 | $34,590,855.40 | - | - | - | |
| Jul 17, 2026 | BEIGF Beone Medicines AG | Chief Executive Officer | Sale+OE10b5-1 | 64,628 | $312.00 | $20,163,906.53 | - | - | - | |
| Jul 16, 2026 | BEIGF Beone Medicines AG | Chief Executive Officer | Sale+OE10b5-1 | 245,575 | $315.30 | $77,428,843.66 | - | - | - | |
| Jul 14, 2026 | BEIGF Beone Medicines AG | Chief Executive Officer | Sale+OE10b5-1 | 145,861 | $305.95 | $44,626,424.10 | - | - | - | |
| Jul 13, 2026 | BEIGF Beone Medicines AG | Chief Executive Officer | Sale+OE10b5-1 | 60,218 | $303.18 | $18,256,807.71 | - | - | - | |
| Jun 23, 2026 | ONC Beone Medicines AG | Chief Executive Officer | Sell | 3,410 | $273.78 | $933,592.21 | -100% | +32.4% | - | |
| Jun 16, 2026 | ONC Beone Medicines AG | Chief Executive Officer | Sell | 3,693 | $265.55 | $980,686.48 | -100% | +34.1% | - | |
| Jun 11, 2026 | ONC Beone Medicines AG | Chief Executive Officer | Sell | 1,949 | $257.24 | $501,354.72 | -100% | +34.9% | - | |
| Jun 8, 2026 | ONC Beone Medicines AG | Chief Executive Officer | Sell | 4,940 | $270.56 | $1,336,547.59 | -100% | +29.8% | - |